Detalhe da pesquisa
1.
Characteristics of subjective cognitive decline associated with amyloid positivity.
Alzheimers Dement
; 18(10): 1832-1845, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877782
2.
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey.
Int J Geriatr Psychiatry
; 36(2): 324-333, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896040
3.
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
Alzheimers Dement
; 13(3): 274-284, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341065
4.
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
Alzheimers Dement
; 13(3): 285-295, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341066
5.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA
; 313(19): 1924-38, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988462
6.
[Pharmacological treatment of behavioral symptoms in dementia patients]. / Farmakologiczne leczenie zaburzen zachowania u osób z otepieniem.
Przegl Lek
; 71(4): 215-20, 2014.
Artigo
em Polonês
| MEDLINE | ID: mdl-25141581
7.
Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases.
Sci Rep
; 13(1): 20869, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012217
8.
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Med Sci Monit
; 17(12): MT105-11, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22129910
9.
Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.
J Alzheimers Dis
; 72(4): 1059-1075, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31683476
10.
Association between genetic and environmental factors and the risk of Alzheimer's disease.
Folia Neuropathol
; 46(4): 249-54, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19169966
11.
The Erlangen Score Algorithm in the diagnosis and prediction of the progression from subjective cognitive decline and mild cognitive impairment to Alzheimer-type dementia.
Folia Neuropathol
; 56(2): 88-96, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30509028
12.
Association of Cerebral Amyloid-ß Aggregation With Cognitive Functioning in Persons Without Dementia.
JAMA Psychiatry
; 75(1): 84-95, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188296
13.
Prediction of deterioration of mild cognitive impairment with CT and SPECT.
Med Sci Monit
; 13 Suppl 1: 31-7, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17507882
14.
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Oncotarget
; 8(10): 16122-16143, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28179587
15.
Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
J Alzheimers Dis
; 54(1): 157-68, 2016 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27472875
16.
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.
J Alzheimers Dis
; 52(1): 51-64, 2016 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26967210
17.
CYP46: a risk factor for Alzheimer's disease or a coincidence?
Neurosci Lett
; 383(1-2): 105-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15936520
18.
[Alzheimer's disease therapy--theory and practice]. / Terapia choroby Alzheimera--teoria a praktyka.
Wiad Lek
; 58(9-10): 528-35, 2005.
Artigo
em Polonês
| MEDLINE | ID: mdl-16529064
19.
Evaluation of the safety profile of Zolafren®, a generic olanzapine formulation, in patients with bipolar disorder: a post-authorization safety study.
Adv Ther
; 32(5): 418-28, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975817
20.
Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.
Int Urol Nephrol
; 47(3): 431-40, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25673555